Related Articles
Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors
EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases
Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: Possible implications for targeted therapy
Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue
Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity